Correlation Between Affimed NV and Abeona Therapeutics
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Abeona Therapeutics, you can compare the effects of market volatilities on Affimed NV and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Abeona Therapeutics.
Diversification Opportunities for Affimed NV and Abeona Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Affimed and Abeona is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Affimed NV i.e., Affimed NV and Abeona Therapeutics go up and down completely randomly.
Pair Corralation between Affimed NV and Abeona Therapeutics
Given the investment horizon of 90 days Affimed NV is expected to under-perform the Abeona Therapeutics. In addition to that, Affimed NV is 2.33 times more volatile than Abeona Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Abeona Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 641.00 in Abeona Therapeutics on September 1, 2024 and sell it today you would lose (2.00) from holding Abeona Therapeutics or give up 0.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Affimed NV vs. Abeona Therapeutics
Performance |
| Timeline |
| Affimed NV |
| Abeona Therapeutics |
Affimed NV and Abeona Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Affimed NV and Abeona Therapeutics
The main advantage of trading using opposite Affimed NV and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.| Affimed NV vs. Tff Pharmaceuticals | Affimed NV vs. Eliem Therapeutics | Affimed NV vs. Inhibrx | Affimed NV vs. Enliven Therapeutics |
| Abeona Therapeutics vs. Tff Pharmaceuticals | Abeona Therapeutics vs. Eliem Therapeutics | Abeona Therapeutics vs. Inhibrx | Abeona Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |